Announcements Trials
Browse Landscape

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Plasma cell 1Myeloid 1Lymphoid 1

Conditions

Postural Orthostatic Tachycardia Syndrome 1Multiple Myeloma 1Mastocytosis 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Surveys and Questionnaires 18Blood Specimen Collection 16Specimen Handling 12Observation 6Magnetic Resonance Spectroscopy 6Surgical Procedures, Operative 5Radiotherapy 5trastuzumab deruxtecan 4ribociclib 4darolutamide 4Standard of Care 4Patient Reported Outcome Measures 4Letrozole 4Data Collection 4Cryosurgery 4Breath Tests 4Tomography, X-Ray Computed 3Radiation 3Neoadjuvant Therapy 3Magnetic Resonance Imaging 3Biopsy 3Anastrozole 3lorlatinib 2cemiplimab 2atezolizumab 2Ultrasonography 2Trastuzumab 2Staining and Labeling 2Restraint, Physical 2Positron-Emission Tomography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Mass Screening × 30 days × Clear all
NCT07143669 2026-05-22

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Blueprint Medicines Corporation

Recruiting
450 enrolled
MyeloidOther hematologic neoplasm

Mastocytosis, Leukemia, Myelomonocytic, Chronic, Postural Orthostatic Tachycardia Syndrome

NCT05844033 2026-05-19

Biomarker for Infection Risk in CLL and MM

Massachusetts General Hospital

Active not recruiting
150 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡